Fluorinov Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $31.7M

Fluorinov Pharma General Information

Description

Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's services include developing small molecule product portfolio for Multiple Myeloma, Waldenström's Macroglobulinemia, Leukemia, Glioblastoma, Lung and Pancreatic Cancers and Central Nervous System disorders, enabling patients to avail therapeutics to treat and avoid cancer diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 101 College Street, MaRS Centre, South Tower
  • Suite 300, L-349
  • Toronto, Ontario M5G 1L7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 101 College Street, MaRS Centre, South Tower
  • Suite 300, L-349
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluorinov Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Jan-2016 $31.7M Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC 07-Jan-2015 Completed Generating Revenue
2. Early Stage VC 07-Jun-2012 $1.47M $1.47M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Generating Revenue
To view Fluorinov Pharma’s complete valuation and funding history, request access »

Fluorinov Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The co
Drug Discovery
Toronto, Canada

Ahmedabad, India
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fluorinov Pharma Competitors (27)

One of Fluorinov Pharma’s 27 competitors is Intas Pharmaceuticals, a Private Equity-Backed company based in Ahmedabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Biocon Biologics Formerly PE-Backed Bengaluru, India
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 27 competitors. Get the full list »

Fluorinov Pharma Patents

Fluorinov Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190016689-A1 Novel fluorinated quinazoline derivatives as egfr inhibitors Inactive 06-Jan-2016
CA-2881986-A1 Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors Inactive 21-Aug-2012

Fluorinov Pharma Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
FACIT Venture Capital Minority
Ontario Brain Institute Accelerator/Incubator
Ontario Institute for Cancer Research Not-For-Profit Venture Capital Minority
To view Fluorinov Pharma’s complete investors history, request access »

Fluorinov Pharma FAQs

  • When was Fluorinov Pharma founded?

    Fluorinov Pharma was founded in 2008.

  • Where is Fluorinov Pharma headquartered?

    Fluorinov Pharma is headquartered in Toronto, Canada.

  • What industry is Fluorinov Pharma in?

    Fluorinov Pharma’s primary industry is Drug Discovery.

  • Is Fluorinov Pharma a private or public company?

    Fluorinov Pharma is a Private company.

  • What is the current valuation of Fluorinov Pharma?

    The current valuation of Fluorinov Pharma is .

  • What is Fluorinov Pharma’s current revenue?

    The current revenue for Fluorinov Pharma is .

  • How much funding has Fluorinov Pharma raised over time?

    Fluorinov Pharma has raised $1.47M.

  • Who are Fluorinov Pharma’s investors?

    FACIT, Ontario Brain Institute, and Ontario Institute for Cancer Research have invested in Fluorinov Pharma.

  • Who are Fluorinov Pharma’s competitors?

    Intas Pharmaceuticals, Biocon Biologics, Gesynta Pharma, Ability Pharma, and Genentech are some of the 27 competitors of Fluorinov Pharma.

  • When was Fluorinov Pharma acquired?

    Fluorinov Pharma was acquired on 27-Jan-2016.

  • Who acquired Fluorinov Pharma?

    Fluorinov Pharma was acquired by Trillium Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process